A Single-Center, Randomized, Double-blind, Placebo-controlled, Phase 1, Single Ascending Dose Safety, Tolerability, and Pharmacokinetic Study of TNX-201 Capsules in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 26 May 2016
At a glance
- Drugs Cyclobenzaprine (Primary) ; Isometheptene
- Indications Fibromyalgia; Post-traumatic stress disorders
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Tonix Pharmaceuticals Inc
- 16 May 2016 Status changed from active, no longer recruiting to completed.
- 09 Apr 2015 Planned End Date changed from 1 Jan 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 09 Apr 2015 Planned primary completion date changed from 1 Dec 2014 to 1 May 2015 as reported by ClinicalTrials.gov.